Recent News | Press Release

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 24, 2025 9:03:19 AM

The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Accl...

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 22, 2025 8:45:24 AM

White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2025) - Envoy Medical® Inc. (NASDAQ: COC...

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Sep 19, 2025 8:32:25 AM

Patent covers advanced signal processing for middle ear sensors, further advancing the Company's pos...

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Sep 10, 2025 9:16:45 AM

Highlights include Expanded Global Patent Portfolio, Complete Debt Elimination Strengthening Balance...

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Sep 9, 2025 9:50:17 AM

Patents strengthen Envoy Medical's innovation pipeline and protect next-generation cochlear implant ...

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Sep 3, 2025 8:37:10 AM

No Serious Adverse Events or Unanticipated Device Effects Reported; Company Confirms Program Remains...

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Aug 26, 2025 9:15:59 AM

Extinguishment simplifies capital structure, strengthens foundation for growth, and eliminates all t...

Blue background with light blue soundwave and Press Release written in white

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Aug 20, 2025 8:50:52 AM

Patents issued in the U.S., Australia, and Hong Kong advance Envoy Medical's innovation pipeline and...

Envoy Medical Reports on Second Quarter 2025 Results

Jul 31, 2025 9:15:55 AM

White Bear Lake, Minnesota--(Newsfile Corp. - July 31, 2025) - Envoy Medical ® , Inc. (NASDAQ: COCH)...

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Jul 8, 2025 9:33:13 AM

White Bear Lake, Minnesota--(Newsfile Corp. - July 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("E...

*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.

**See Important Information here.

News Room